Skip to main content
. 2024 Jan 18;24:221. doi: 10.1186/s12889-024-17699-4

Table 2.

Associations between inflammatory markers and infertility

Inflammatory markers Total, n Infertility, n Crude Model Model 1 Model 2 Model 3
OR (95%CI) P OR (95%CI) P OR (95%CI) P OR (95%CI) P
log2-SII 3105 431 0.95 (0.78, 1.15) 0.60 0.91 (0.74, 1.10) 0.32 0.82 (0.66, 1.02) 0.07 0.82 (0.66, 1.02) 0.08
 Q1 [5.40, 8.45] 778 117 ref ref ref ref
 Q2 (8.45, 8.93] 774 106 0.87 (0.61, 1.25) 0.45 0.81 (0.57, 1.17) 0.26 0.77 (0.53, 1.11) 0.16 0.77 (0.52, 1.12) 0.17
 Q3 (8.93, 9.38] 776 92 0.71 (0.49, 1.03) 0.07 0.65 (0.44, 0.95) 0.03 0.57 (0.38, 0.85) 0.01 0.56 (0.37, 0.85) 0.01
 Q4 (9.38, 12.51] 777 116 1.08 (0.76, 1.53) 0.65 0.97 (0.68, 1.38) 0.87 0.83 (0.55, 1.25) 0.37 0.83 (0.55, 1.27) 0.38
log2-LC 3105 431 1.42 (1.00, 2.00) 0.05 1.51 (1.06, 2.16) 0.02 1.33 (0.93, 1.90) 0.12 1.33 (0.93, 1.92) 0.12
 Q1 [-1.00, 0.93] 959 124 Ref Ref Ref Ref
 Q2 (0.93, 1.20] 768 86 0.77 (0.53, 1.11) 0.16 0.79 (0.55, 1.12) 0.17 0.72 (0.51, 1.03) 0.07 0.72 (0.51, 1.03) 0.07
 Q3 (1.20, 1.43] 603 93 1.06 (0.75, 1.50) 0.74 1.08 (0.75, 1.57) 0.67 0.97 (0.67, 1.40) 0.86 0.98 (0.68, 1.40) 0.90
 Q4 (1.43, 2.72] 775 128 1.46 (1.04, 2.03) 0.03 1.55 (1.11, 2.18) 0.01 1.36 (0.95, 1.94) 0.09 1.35 (0.94, 1.94) 0.10
log2-PPN 3105 431 1.17 (0.94, 1.47) 0.15 1.17 (0.92, 1.47) 0.19 1.01 (0.79, 1.28) 0.95 1.01 (0.79, 1.28) 0.94
 Q1 [8.00, 10.47] 778 95 Ref Ref Ref Ref
 Q2 (10.47, 10.89] 774 121 1.52 (1.02, 2.26) 0.04 1.57 (1.05, 2.35) 0.03 1.38 (0.92, 2.08) 0.11 1.38 (0.92, 2.07) 0.11
 Q3 (10.89, 11.30] 777 101 1.13 (0.77, 1.66) 0.53 1.13 (0.77, 1.66) 0.52 0.96 (0.64, 1.45) 0.85 0.96 (0.63, 1.44) 0.82
 Q4 (11.30, 13.42] 776 114 1.50 (1.04, 2.15) 0.03 1.52 (1.03, 2.24) 0.03 1.19 (0.79, 1.79) 0.39 1.20 (0.80, 1.79) 0.37
log2-PLR 3105 431 0.80 (0.60, 1.05) 0.10 0.74 (0.56, 0.98) 0.04 0.76 (0.57, 1.01) 0.06 0.76 (0.57, 1.00) 0.05
 Q1 [3.68, 6.56] 779 123 Ref Ref Ref Ref
 Q2 (6.56, 6.85] 773 116 0.82 (0.58, 1.14) 0.23 0.82 (0.58, 1.17) 0.26 0.82 (0.57, 1.17) 0.26 0.83 (0.57, 1.19) 0.30
 Q3 (6.85, 7.16] 777 92 0.64 (0.45, 0.89) 0.01 0.61 (0.43, 0.87) 0.01 0.60 (0.42, 0.87) 0.01 0.61 (0.43, 0.88) 0.01
 Q4 (7.16, 8.82] 776 100 0.82 (0.57, 1.17) 0.26 0.75 (0.52, 1.07) 0.11 0.76 (0.52, 1.11) 0.15 0.75 (0.51, 1.10) 0.13
log2-NLR 3105 431 0.87 (0.58, 1.29) 0.48 0.79 (0.53, 1.19) 0.26 0.73 (0.46, 1.16) 0.18 0.73 (0.46, 1.18) 0.19
 Q1 [0.61, 1.45] 778 115 Ref Ref Ref Ref
 Q2 (1.45, 1.69] 782 104 0.84 (0.60, 1.18) 0.30 0.78 (0.55, 1.10) 0.15 0.72 (0.51, 1.02) 0.06 0.71 (0.50, 1.02) 0.06
 Q3 (1.69, 1.93] 772 104 0.86 (0.59, 1.25) 0.43 0.76 (0.53, 1.11) 0.15 0.72 (0.49, 1.06) 0.10 0.72 (0.49, 1.06) 0.10
 Q4 (1.93, 3.86] 773 108 0.98 (0.70, 1.36) 0.89 0.89 (0.64, 1.23) 0.46 0.81 (0.57, 1.16) 0.24 0.81 (0.56, 1.16) 0.24
log2-LMR 3105 431 1.05 (0.78, 1.41) 0.77 1.07 (0.79, 1.45) 0.64 0.99 (0.72, 1.37) 0.97 1.01 (0.73, 1.39) 0.96
 Q1 [0.11, 1.81] 770 96 Ref Ref Ref Ref
 Q2 (1.81, 2.12] 767 114 1.53 (1.01, 2.30) 0.04 1.48 (0.99, 2.22) 0.05 1.49 (0.99, 2.23) 0.06 1.47 (0.98, 2.20) 0.06
 Q3 (2.12, 2.43] 827 119 1.33 (0.87, 2.03) 0.19 1.28 (0.83, 1.98) 0.26 1.18 (0.74, 1.89) 0.47 1.20 (0.75, 1.91) 0.44
 Q4 (2.43, 4.03] 741 102 1.14 (0.78, 1.65) 0.49 1.18 (0.81, 1.71) 0.39 1.12 (0.76, 1.63) 0.56 1.12 (0.77, 1.64) 0.54

Crude model was not adjusted. Model 1 was adjusted age(continuous). Model 2 was adjusted for model 1 + BMI (continuous), race (Mexican, Hispanic, White, Black, and Other race), marital status (living alone, and married/living with partner), education (Some college or AA degree above, High school or GED, and Less than 11th grade), smoking status (No, Yes), alcohol user (never, former, mild, and heavy) and PIR (< 1.5, 1.5–3.5, and ≥ 3.5). Model 3 was adjusted for model 2 + PID (No, Yes), and age of menarche (< 15 years or ≥ 15 years). P value in bold indicates statistical significance

Abbreviation: OR odds ratios, CI confidence interval, ref reference group, SII systemic immune inflammation index, LC lymphocyte count, PPN product of platelet and neutrophil count, PLR platelet-lymphocyte ratio, NLR neutrophil–lymphocyte ratio, LMR lymphocyte-monocyte ratio, Q1 the first quartile, Q2 the second quartile, Q3 the third quartile, Q4 the highest quartile